Jocelyn C. Reader
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 11
- Chemokine receptors and signaling 3
- Cytokine Signaling Pathways and Interactions 3
-
- Inflammatory mediators and NSAID effects 7
- Co-authors
- Amy M. Fulton (11 shared papers)Dawn M. Holt (2 shared papers)Xinrong Ma (6 shared papers)Namita Kundu (6 shared papers)Dana M. Roque (9 shared papers)Yi Ning (6 shared papers)Olga G. Goloubeva (5 shared papers)Tyler J. Kochel (4 shared papers)
- Journals
- Cancers (4 papers)Leukemia (3 papers)Proceedings of the National Academy of Sciences (2 papers)Frontiers in Pharmacology (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Jocelyn C. Reader
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Pharmacology 234
- Oncology 302
- Cancer Research 151
- Hematology 113
- Immunology 202
Countries citing papers authored by Jocelyn C. Reader
This map shows the geographic impact of Jocelyn C. Reader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn C. Reader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn C. Reader more than expected).
Fields of papers citing papers by Jocelyn C. Reader
This network shows the impact of papers produced by Jocelyn C. Reader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn C. Reader. The network helps show where Jocelyn C. Reader may publish in the future.
Co-authors
The 25 scholars most cited alongside Jocelyn C. Reader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 135 | |
| 2 | 2021 | 108 | |
| 3 | 2020 | 98 | |
| 4 | 2013 | 88 | |
| 5 | 1995 | 84 | |
| 6 | 2006 | 74 | |
| 7 | 2013 | 57 | |
| 8 | 2007 | 55 | |
| 9 | 2018 | 53 | |
| 10 | 2007 | 53 | |
| 11 | 2016 | 50 | |
| 12 | 2010 | 41 | |
| 13 | 2014 | 32 | |
| 14 | 2010 | 30 | |
| 15 | 2022 | 27 | |
| 16 | 2019 | 22 | |
| 17 | 2007 | 20 | |
| 18 | 2019 | 17 | |
| 19 | 2020 | 13 | |
| 20 | 2022 | 10 |
About Jocelyn C. Reader
Jocelyn C. Reader is a scholar working on Oncology, Pharmacology, Genetics, Psychiatry and Mental health and Cancer Research, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (5 papers), Cancer, Stress, Anesthesia, and Immune Response (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Chemokine receptors and signaling (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Pharmacology (234 citations), Oncology (302 citations), Cancer Research (151 citations), Hematology (113 citations) and Immunology (202 citations). Jocelyn C. Reader has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Amy M. Fulton, Dawn M. Holt, Xinrong Ma, Namita Kundu, Dana M. Roque, Yi Ning, Olga G. Goloubeva, Tyler J. Kochel, Cong Fan and Yukinori Take. Their work appears in journals such as Cancers, Leukemia, Proceedings of the National Academy of Sciences, Frontiers in Pharmacology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.